Cytagil Iv 50 mg Powder for solution for infusion.
PDF Leaflet Revision Date: 25 April 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Severe life-threatening infections in adults.
Dosage (summary)
Initial 100 mg IV, then 50 mg every 12 hours.
Onset of Action / Duration
Onset: 30 mins, Duration: 5-14 days
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not recommended during pregnancy or lactation.
Key Drug Interactions
- Warfarin
- Calcineurin inhibitors
- Oral contraceptives
Contraindications
- Hypersensitivity to tigecycline
- Pregnancy
- Lactation
Common side effects
- Nausea
- Vomiting
- Dizziness
- Pneumonia
Counselling Points
- Monitor for superinfection
- Use additional contraception
- Caution in hepatic impairment
Serious warnings
- Anaphylaxis
- Hepatic failure
- Superinfection risk
Important Disclaimer
The Cytagil Iv 50 mg Powder for solution for infusion. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
